Zusammenfassung
Hintergrund
Blutungen sind eine der häufigsten vermeidbaren Todesursachen beim Trauma, die durch eine adäquate chirurgische Blutstillung, frühzeitige und ausreichende Gerinnungstherapie behandelt werden können.
Fragestellung
Konnten durch die Einführung einer frühen Standard Operating Procedure (SOP), die sich auf Gerinnungsfaktoren stützt und am im Schockraum bestimmten Hämoglobingehalt (SR-Hb) orientiert, eine Reduktion der standardisierten Mortalitätsrate (SMR, beobachtete Letalität: prognostizierte Letalität) und eine Reduktion des Transfusionsbedarfs bei Massivtransfusion(MT)-pflichtigen Traumapatienten erreicht werden?
Methode
Retrospektive, monozentrische Untersuchung an einem überregionalen Traumazentrum mithilfe eines „Vorher-Nachher“-Vergleichs im Zeitraum 2005–2014. Verglichen wurden die Kohorte der MT-pflichtigen Patienten vor Einführung einer „Gerinnung-SOP“ (Gruppe 1) und die Kohorte danach (Gruppe 2).
Ergebnisse
Von 952 versorgten Patienten benötigten 86 (9%) eine MT. Dabei entfielen 45 Patienten auf die Gruppe 1 und 41 Patienten auf die Gruppe 2. Beide Gruppen waren hinsichtlich Verletzungsschwere, im Schockraum erhobener Hämostaseparameter und Geschlechtsverteilung nahezu ähnlich. Jedoch zeigten sich signifikante Unterschiede in der Thrombozytenzahl bei Schockraumaufnahme (159 Gpt/l in Gruppe 1 vs. 124 Gpt/l in Gruppe 2) und in der nach Revised Injury Severity Classification (RISC) prognostizierten Letalität (46,5 % in Gruppe 1 vs. 65,3 % in Gruppe 2). Die SMR sank von 0,95 in Gruppe 1 auf 0,72 in Gruppe 2. Der Transfusionsbedarf an Erythrozyten in Gruppe 2 war signifikant niedriger, und wesentliche Hämostaseparameter bei Intensivaufnahme waren signifikant besser. Gruppe 2 erhielt signifikant häufiger gerinnungsaktive Substanzen.
Schlussfolgerung
Ein frühes, auf Gerinnungsfaktoren gestütztes standardisiertes Vorgehen in Form einer SOP führt zu einer signifikanten Reduktion des Transfusionsbedarfs an Erythrozytenkonzentraten (EK) und zu einem Trend, die SMR bei MT-pflichtigen Traumapatienten zu reduzieren.
Abstract
Background
Bleeding and trauma-induced coagulopathy (TIC) are major contributors to death related to trauma in the first 24 h and the major preventable contributors. Early surgical therapy and aggressive correction of TIC are key steps to prevent death in patients suffering from hemorrhage. Therefore, a standard operating procedure (SOP) using a hemoglobin (Hb)-oriented and coagulation factor-based algorithm for early correction of TIC was introduced in this level 1 trauma center. This SOP uses the correlation of the Hb values measured in the trauma bay and standard coagulation tests as the basis for various aggressive coagulation therapies.
Objective
The aim was to investigate the effectiveness of the SOP in trauma patients requiring massive transfusions. The main objective was the effect on the transfusion requirements and the standardized mortality ratio (SMR), the ratio of observed deaths to expected/predicted deaths, in the cohort of massively transfused trauma patients after introduction of the SOP compared with a historical cohort.
Method
A retrospective, single center study was carried out at a supraregional trauma center between 2005 and 2014. After introduction of the Hb-oriented, coagulation factor-based SOP for correction of TIC in 2011 a before/after comparison of all trauma patients requiring massive transfusions during trauma bay resuscitation and intensive care unit (ICU) admission was carried out. Main outcome parameters were the transfusion requirement and the SMR. The historical cohort of massively transfused trauma patients before introduction of the SOP (group 1) was compared with the cohort after introduction of the SOP (group 2). Furthermore, the two cohorts were compared regarding injury severity, expected death calculated with the revised injury severity classification (RISC), hemostatic results on trauma bay and ICU admission, clotting therapy and outcome.
Results
Of the 952 patients investigated 86 (9%) required massive transfusion (45 in group 1 and 41 in group 2). Both groups were comparable regarding injury severity but showed slight differences in hemostatic results on trauma bay admission, with a trend to worse results in group 2. Differences were recorded for platelet count on trauma bay admission with significantly lower values in group 2. The RISC predicted a significant difference in the mortality rate (46.5 % group 1 and 65.3 % group 2) but no significant differences in the observed mortality (44.4 % group 1 and 47 % group 2) were recorded. The SMR decreased from 0.95 in group 1 to 0.72 in group 2, meaning that in group 1 from 21 predicated trauma deaths 20 occurred and in group 2 from 27 predicated trauma deaths 19 occurred. This difference is not statistically significant (p = 0.16) due to the small sample size but is clinically relevant. A significant reduction in the requirement of red blood cell transfusions (22.8 ± 8.1 units vs 17.6 ± 7.6 units) was achieved (p = 0.003). Significant differences between the groups were observed regarding frequency and quantity of the coagulation-promoting drugs. Compared with group 1 the SOP used in group 2 achieved significantly better hemostatic results on ICU admission for fibrinogen and Quick’s value and a clear trend to better results for international normalized ratio (INR) and PTT.
Conclusion
The SOP based on coagulation factor values and standardized clotting therapy showed a clear trend to reduction of the SMR in massively transfused trauma patients. On the other hand the SOP achieved a significant reduction in the transfusion requirements and a significant improvement in the hemostatic results in the most severely injured patients. This can be interpreted as an effective use of coagulation factors in the early hospital treatment of trauma patients with ongoing bleeding.
Literatur
Bansal V, Fortlage D, Lee J, Constantini T, Potenza B, Coimbra R (2009) Hemorrhage is more prevalent than brain injury in early trauma deaths: the golden six hours. Eur J Trauma Emerg Surg 35:26–30
Biscoping J (2009) [Therapy with blood components and plasma derivatives: the current cross-sectional guidelines]. Anaesthesist 58:1083–1084
Boffard KD, Riou B, Warren B et al (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8–15
Borgman MA, Spinella PC, Holcomb JB et al (2011) The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang 101:44–54
Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF (2007) Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 245:812–818
Deutsche Gesellschaft für Unfallchirurgie e. V.(DGU) (2011) Polytrauma/Schwerverletzten-Behandlung. AWMF-Register Nr. 012/019 Klasse: S3. http://www.awmf.org/uploads/tx_szleitlinien/012-019l_S3_Polytrauma_Schwerverletzten-Behandlung_2015-01.pdf
Donaubauer B, Fakler J, Gries A, Kaisers UX, Josten C, Bernhard M (2014) [Interdisciplinary management of trauma patients: update 3 years after implementation of the S3 guidelines on treatment of patients with severe and multiple injuries]. Anaesthesist 63(11):852–864
Grottke O (2015) [Individualized coagulation therapy: wish or already reality?]. Anaesthesist. doi:10.1007/s00101-015-0059-x
Grottke O, Frietsch T, Maas M, Lier H, Rossaint R (2013) [Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine]. Anaesthesist 62:213–220, 222
Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M (2005) „Low-dose“ recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 59:150–154
Heim MU, Hellstern P (2010) [New cross-sectional guidelines of the German Medical Association for hemotherapy with fresh frozen plasma. Evidence-based recommendations for risk-benefit assessment]. Anaesthesist 59:80–85
Hilbert P, Hofmann GO, Lefering R, Struck MF (2015) [Trauma bay haemoglobin level: predictor of coagulation disorder in major trauma]. Unfallchirurg 118:601–606
Hilbert P, Hofmann GO, Teichmann J, Struck MF, Stuttmann R (2013) The „coagulation box“ and a new hemoglobin-driven algorithm for bleeding control in patients with severe multiple traumas. Arch Trauma Res 2:3–10
Hilbert P, Hofmann GO, zur Nieden K, Teichmann J, Jakubetz J, Stuttmann R (2012) [Coagulation management of trauma patients with unstabile circulation: establishment of a hemoglobin-oriented standard operating procedure]. Anaesthesist 61:703–710
Hilbert P, Lefering R, Stuttmann R (2010) Trauma care in Germany: major differences in case fatality rates between centers. Dtsch Arztebl Int 107:463–469
Hilbert P, zur Nieden K, Hofmann GO, Hoeller I, Koch R, Stuttmann R (2007) New aspects in the emergency room management of critically injured patients: a multi-slice CT-oriented care algorithm. Injury 38:552–558
Hilbert P, zur Nieden K, Stuttmann R (2005) [D-dimer screening in surgical long-term intensive care patients]. Anaesthesist 54:210–214
Hilbert-Carius P (2015) Trauma-Induzierte-Coagulopathie (TIC) – Reicht zur Diagnose und Therapieentscheidung ein Blick auf die BGA und den Patienten? Anästh Intensivmed 56:S43
Holcomb JB, Fox EE, Wade CE (2015) Mortality and ratio of blood products used in patients with severe trauma – reply. JAMA 313:2078–2079
Holcomb JB, Tilley BC, Baraniuk S et al (2015) Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313:471–482
Hussmann B, Lefering R, Taeger G, Waydhas C, Ruchholtz S (2011) Influence of prehospital fluid resuscitation on patients with multiple injuries in hemorrhagic shock in patients from the DGU trauma registry. J Emerg Trauma Shock 4:465–471
Hussmann B, Taeger G, Lefering R et al (2011) Letalität und Outcome beim Mehrfachverletzten nach schwerem Abdominal- und Beckentrauma. Einfluss der präklinischen Volumengabe - Eine Auswertung von 604 Patienten des TraumaRegisters der DGU. Unfallchirurg 114:705–712
Johansson PI, Stensballe J, Ostrowski SR (2012) Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 20:47
Ker K, Kiriya J, Perel P, Edwards P, Shakur H, Roberts I (2012) Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med 12:3
Khan S, Brohi K, Chana M et al (2014) Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 76:561–567
Khan S, Davenport R, Raza I et al (2015) Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 41:239–247
Kozek-Langenecker SA, Afshari A, Albaladejo P et al (2013) Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30:270–382
Lefering R (2009) Development and validation of the Revised Injury Severity Classification (RISC) score for severely injured patients. Eur J Trauma Emerg Surg 35:437–447
Lefering R, Huber-Wagner S, Nienaber U, Maegele M, Bouillon B (2014) Update of the trauma risk adjustment model of the TraumaRegister DGU: the Revised Injury Severity Classification, version II. Crit Care 18:476
Lier H, Hinkelbein J (2014) [Coagulation therapy in multiple trauma without point-of-care testing]. Unfallchirurg 117:105–110
Lier H, Krep H, Schöchel H (2009) Coagulation management in the treatment of multiple trauma. Anaesthesist 58:1010–1026
Lier H, Bottiger BW, Hinkelbein J, Krep H, Bernhard M (2011) Coagulation management in multiple trauma: a systematic review. Intensive Care Med 37:572–582
Lier H, Kampe S, Schroder S (2007) [Prerequisites of a functional haemostasis. What must be considered at the scene of an accident, in the emergency room and during an operation?]. Anaesthesist 56:239–251
Maegele M, Inaba K, Rizoli S et al (2015) [Early viscoelasticity-based coagulation therapy for severely injured bleeding patients: report of the consensus group on the consensus conference 2014 for formulation of S2k guidelines]. Anaesthesist
Perkins JG, Schreiber MA, Wade CE, Holcomb JB (2007) Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma 62:1095–1099
Riskin DJ, Tsai TC, Riskin L et al (2009) Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 209:198–205
Roberts I, Perel P, Prieto-Merino D et al (2012) Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ 345:e5839
Rossaint R, Bouillon B, Cerny V et al (2013) The STOP the Bleeding Campaign. Crit Care 17:136
Rossaint R, Bouillon B, Cerny V et al (2010) Management of bleeding following major trauma: an updated European guideline. Crit Care 14:R52
Rotondo MF, Schwab CW, McGonigal MD et al (1993) ‚Damage control‛: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 35:375–382
Schlimp CJ, Voelckel W, Inaba K, Maegele M, Ponschab M, Schochl H (2013) Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission. Crit Care 17:R137
Schochl H, Maegele M, Solomon C, Gorlinger K, Voelckel W (2012) Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 20:15
Schochl H, Nienaber U, Hofer G et al (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55
Schochl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ (2014) Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care 18:R147
Spahn DR, Bouillon B, Cerny V et al (2013) Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 17:R76
Wafaisade A, Wyen H, Mutschler M et al (2014) [Current practice in coagulation and transfusion therapy in multiple trauma patients: a German nation-wide online survey]. Unfallchirurg
Weber CF, Zacharowski K, Brun K et al (2013) [Basic algorithm for Point-of-Care based hemotherapy: perioperative treatment of coagulopathic patients]. Anaesthesist 62:464–472
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Hilbert-Carius hat Vortragshonorare von CSL Behring erhalten. G. Hofmann und R. Stuttmann geben an, dass kein Interessenkonflikt besteht.
Alle im vorliegenden Manuskript beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zuständigen Ethik-Kommission (Ethikkommission der Ärztekammer Sachsen-Anhalt), im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patienten liegt eine Einverständniserklärung vor.
Rights and permissions
About this article
Cite this article
Hilbert-Carius, P., Hofmann, G. & Stuttmann, R. „Hämoglobinorientierter und gerinnungsfaktorbasierter Algorithmus“. Anaesthesist 64, 828–838 (2015). https://doi.org/10.1007/s00101-015-0093-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-015-0093-8